Breaking Down Amylyx Pharma: 9 Analysts Share Their Views
Amylyx Pharma (NASDAQ:AMLX) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from…
Amylyx Pharmaceuticals’ Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder
Amylyx's AMX0035 data in treating Wolfram syndrome, with interim data indicating positive effects on diabetes progression, visual decline, and overall disease burden. Safety profile consistent.
Amylyx Pharmaceuticals To Host Virtual Webcast To Discuss Interim Data From Phase 2 HELIOS Study Of AMX0035 In Wolfram Syndrome On April 10, 2024
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announced the Company will host a virtual webcast with management and Fumihiko Urano, MD, PhD, Principal Investigator of the HELIOS clinical
Unveiling 6 Analyst Insights On Amylyx Pharma
In the last three months, 6 analysts have published ratings on Amylyx Pharma (NASDAQ:AMLX), offering a diverse range…
Amylyx Pharmaceuticals Announces First Participant Dosed In The Global Phase 3 ORION Study Of AMX0035 In Progressive Supranuclear Palsy
- Largest ever PSP clinical trial will evaluate the efficacy and safety of AMX0035 in adults with PSP compared to placebo- Trial to enroll approximately 600 participants across the U.S., Canada, Europe, and JapanAmylyx
Amylyx Pharmaceuticals Announces Publication Of Data Showing The Effect Of AMX0035 On Plasma Neuroinflammatory Biomarkers In ALS
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announced the publication of analyses performed on neuroinflammatory biomarkers using plasma samples from participants with amyotrophic lateral
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Intelligent Bio Solutions (NASDAQ:INBS) shares increased by 72.0% to $0.39 during Thursday’s pre-market session. The market value…
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell
• Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
Earnings Preview For Amylyx Pharma
Amylyx Pharma (NASDAQ:AMLX) is set to give its latest quarterly earnings report on Thursday, 2023-11-09. Here’s what investors…